Inflammatory biomarkers of obstructive sleep apnea: a comprehensive review from known to novel
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-13128-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 06.11.2026. Verfasst von Sana Esmaeeli. Beteiligte Einrichtung: Pharmaceutical Analysis Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences, Tabriz, Iran. sana.esmaeeli.resear…. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Biomarkers, Inflammation. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Obstructive sleep apnea (OSA) is a frequent condition that disrupts breathing during sleep and contributes to cardiovascular, metabolic, and cognitive problems. While intermittent hypoxia and oxidative stress are well known mechanisms, inflammation has gained attention as a central driver of disease. In recent years, researchers have examined a wide range of inflammatory biomarkers, from established ones such as tumor necrosis factor α (TNF-α), c-reactive protein (CRP), and interleukins, to newer candidates including interferon gamma (IFN-γ), fractalkine, serum amyloid A (SAA), monocyte chemoattractant protein-1 (MCP-1), toll-like receptor (TLR), YKL-40, S100 proteins, neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), galectin-3, neopterin, and pentraxin 3 (PTX3). Many of these markers show links with OSA severity and cardiovascular risk, though findings are not always consistent. Treatment with continuous positive airway pressure (CPAP) can lower some inflammatory markers, suggesting a role for biomarker monitoring in therapy. At the same time, advances in omics and artificial intelligence are opening new paths for discovery of novel biomarkers. This review aims to bring together current knowledge on classical and new inflammatory biomarkers in OSA, and to outline their potential roles in screening diagnosis, risk assessment, and treatment for the future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Analysis Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences, Tabriz, Iran. sana.esmaeeli.researcher@gmail.com.
ORCID-Profile: Sana Esmaeeli
Zitieren
APA
Esmaeeli, S. (2026). Inflammatory biomarkers of obstructive sleep apnea: a comprehensive review from known to novel. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13128-4
Vancouver
Esmaeeli S. Inflammatory biomarkers of obstructive sleep apnea: a comprehensive review from known to novel. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13128-4
BibTeX
@article{Esmaeeli2026,
author = {Esmaeeli, Sana},
title = {Inflammatory biomarkers of obstructive sleep apnea: a comprehensive review from known to novel},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-13128-4}
}
EUVIMED